Johnson & Johnson suspends sales forecast for COVID-19 vaccine
(Reuters) -Johnson & Johnson on Tuesday suspended the sales forecast for its COVID-19 vaccine due to global supply surplus and demand uncertainty, sending its shares down 2.6% in premarket trading.

19-04-2022